Chinese Network of Pediatric Antiretroviral Therapy

Completed

• Conditions: Acquired Immunodeficiency Syndrome

• Registration Number: NCT01210924
• Lead Sponsor: National Center for AIDS/STD Control and Prevention, China CDC

Brief Summary

This is an observational cohort in pediatric HIV patients in China. Children who receive antiretroviral drugs will be recruited in this study. The main objectives are as follows: 1. To establish simpler and smarter pediatric antiretroviral therapy in China including both first-line and second-line regimens. 2. To study the nature, characteristics and mechanisms of immunoreconstitution in HIV-infected children using the data and samples from the pediatric antiretroviral therapy cohort. 3. To establish a basic science and clinical research network based on the pediatric antiretroviral cohort.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-04
• Study First Submitted: 2010-09-27
• Study First Submitted QC: 2010-09-27
• Study First Posted: 2010-09-29
• Status Verified: 2013-11
• Primary Completion: 2015-12
• Study Completion: 2015-12
• Last Update Submitted: 2018-03-28
• Last Update Posted: 2018-03-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

• clinical diagnosis of HIV infection
• receiving triple antiretroviral drugs

Exclusion Criteria

• clinical status not stable

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The immunology and virologic outcomes	2016

Trial Locations

Locations (1)

National Center for AIDS/STD Control and Prevention, China Center for Disease Control and Prevention; 🇨🇳 Beijing, China